Do the genotypic assays for the detection of antiretroviral resistance represent a useful tool in the management of HIV-infected patients? The rationale for this legal proceeding is all included in this question. No health care technology assessment has been performed on antiretroviral genotypic assays in HIV-infected patients. Assays to measure drug resistance are available only in specialized laboratories and warnings are related to possible expanded use of these assays in the absence of randomised studies with prolonged clinical endpoint and in the absence of unambiguous and exhaustive general recommendations for the use of resistance assays in clinical practice.
|Number of pages||4|
|Journal||Scandinavian Journal of Infectious Diseases, Supplement|
|Publication status||Published - Dec 2003|
ASJC Scopus subject areas
- Microbiology (medical)
- Immunology and Microbiology(all)
- Infectious Diseases